ResMed, a San Diego-based maker of products for sleep disorders, announced Monday it will buy the medical software company Brightree for $800 million. Privately held Brightree, based in Atlanta, makes ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Respiratory specialist ResMed ($RMD) announced that it is acquiring software company Brightree for $800 million in a bid to provide administrative solutions like ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Expands ResMed’s sleep management software solution, will help sleep labs and physicians more efficiently guide patients into and through diagnosis to long-term treatment Diagnostic management ...
San Diego’s ResMed, best-known for its sleep apnea devices and ventilators, has inked a deal to buy German health care software outfit MediFox Dan in an all-cash deal valued at $1 billion. The ...
ResMed, the medical device maker based in San Diego, has acquired cloud-based software provider Brightree for $800 million. The purchase marks the third acquisition in the space of just eight months ...
Cloud-powered medical device company ResMed has agreed to buy German healthcare software firm Medifox Dan for $1 billion. ResMed, based in San Diego, said it will integrate Medifox Dan’s capabilities ...
Connected respiratory device maker ResMed signed a definitive agreement to acquire Medifox Dan, a German out-of-hospital software company, from software investor Hg for $1 billion (€950 million).
Still taking advantage of the fact that competitor Philips’ respiratory care business remains stanched by its ongoing CPAP machine recall, ResMed continues to carve out an even bigger foothold for ...
ResMed, which makes medical equipment and home health management software, said it will acquire MatrixCare in a deal valued at $750 million. MatrixCare, which provides acute long-term healthcare ...